Alberti Andrea, Conte Francesca, Costagli Sara, Cadenar Anna, Nicoletti Rossella, Pecoraro Alessio, Sebastianelli Arcangelo, Teoh Jeremy Yuen Chun, Cicione Antonio, Autorino Riccardo, Woo Henry H, De Groote Ruben, Elterman Dean, Drake Marcus, Gravas Stavros, Ficarra Vincenzo, De Nunzio Cosimo, Serni Sergio, Campi Riccardo, Gacci Mauro
Unit of Urological Robotic Surgery and Renal Transplantation, University of Florence, Careggi Hospital, Florence, Italy.
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Prostate Cancer Prostatic Dis. 2025 Apr 18. doi: 10.1038/s41391-025-00973-w.
Since Endoscopic Enucleation of the Prostate [EEP] and Robot-Assisted Simple Prostatectomy [RASP] showed comparable functional results, treatment selection is often based on clinicians' and patients' preferences. The aim of this systematic review was to compare Patient-Reported Outcomes Measures [PROMs] and Patient-Reported Experience Measures [PREMs] in patients with large prostate glands treated with EEP and RASP.
Literature search was performed on August 29 2024 using the MEDLINE, EMBASE, and Cochrane CENTRAL databases, following the EAU Guidelines Office and the PRISMA statement recommendations. All comparative studies reporting validated PROMs/PREMs for both interventions (EEP and RASP) were included. Studies reporting within-treatment comparisons only (e.g., HoLEP vs. ThuLEP) were excluded.
Ten studies involving 1105 patients (430 RASP, 675 EEP) were included in this systematic review. Follow-up ranged from 2 to 24 months. Considering urinary function, all authors reported a great improvement for both EEP and RASP at short- and mid-term, with no significant differences between endoscopic and robotic procedures. Alongside the lower symptom scores, patient-reported Quality of Life [QoL] significantly improved for both techniques. Erectile function remained stable after EEP and RASP in most of the studies, while some of them even reported a significant improvement. No studies reporting PREMs were retrieved.
Both RASP and EEP led to a great improvement in urinary function and QoL, safeguarding sexual function, with no significant difference between the different techniques in terms of functional outcomes. None of the included studies reported PREMs. A standardization of PROMs/PREMs and their integration in clinical practice is warranted, to understand the real impact of these treatments, helping physicians and patients for an individualized shared decision-making process.
由于前列腺内镜剜除术[EEP]和机器人辅助单纯前列腺切除术[RASP]显示出相当的功能结果,治疗选择通常基于临床医生和患者的偏好。本系统评价的目的是比较接受EEP和RASP治疗的大前列腺患者的患者报告结局指标[PROMs]和患者报告体验指标[PREMs]。
2024年8月29日,按照欧洲泌尿外科学会指南办公室和PRISMA声明的建议,使用MEDLINE、EMBASE和Cochrane CENTRAL数据库进行了文献检索。纳入了所有报告两种干预措施(EEP和RASP)有效PROMs/PREMs的比较研究。仅报告治疗内比较的研究(例如,HoLEP与ThuLEP)被排除。
本系统评价纳入了10项研究,涉及1105例患者(430例RASP,675例EEP)。随访时间为2至24个月。考虑到排尿功能,所有作者均报告EEP和RASP在短期和中期均有显著改善,内镜手术和机器人手术之间无显著差异。除了较低的症状评分外,两种技术的患者报告生活质量[QoL]均显著改善。在大多数研究中,EEP和RASP术后勃起功能保持稳定,其中一些研究甚至报告有显著改善。未检索到报告PREMs的研究。
RASP和EEP均使排尿功能和QoL有显著改善,性功能得到保护,不同技术在功能结局方面无显著差异。纳入的研究均未报告PREMs。有必要对PROMs/PREMs进行标准化并将其纳入临床实践,以了解这些治疗的实际影响,帮助医生和患者进行个体化的共同决策过程。